Translations:Benfotiamine/1/ja: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 449055379 | IUPAC_name = ''S''-[2-{[(4-Amino-2-methylpyrimidin-5-yl)methyl] (formyl)amino}-5-(phosphonooxy)pent-2-en-3-yl] benzenecarbothioate | image = Benfotiamine.svg | image2 = Benfotiamine ball-and-stick.png <!--Clinical data--> | tradename = Milgamma | Drugs.com = {{drugs.com|international|benfotiamine}} | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B..." |
(No difference)
|
Latest revision as of 09:19, 3 April 2024
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Milgamma |
Other names | S-Benzoylthiamine O-monophosphate |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C19H23N4O6PS |
Molar mass | 466.45 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |